Zydus Cadila’s Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine being tested for use in the age group of 2-18 yrs – is also likely to get a go-ahead by September., Zydus Cadila’s Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine being tested for use in the age group of 2-18 yrs – is also likely to get a go-ahead by September., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way